UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039841
Receipt number R000045438
Scientific Title Elucidation of neuroscientific evidence of the effects of cognitive behavioral therapy for eating disorders
Date of disclosure of the study information 2020/03/18
Last modified on 2023/09/19 13:31:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Eating Disorder Neuroimaging Initiative

Acronym

EDNI

Scientific Title

Elucidation of neuroscientific evidence of the effects of cognitive behavioral therapy for eating disorders

Scientific Title:Acronym

Elucidation of neuroscientific evidence of the effects of cognitive behavioral therapy for eating disorders

Region

Japan


Condition

Condition

Eating disorders

Classification by specialty

Psychosomatic Internal Medicine Psychiatry Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To elucidate neuroscientific evidence of the effects of cognitive behavioral therapy for eating disorders

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

EDE interview

Key secondary outcomes

Remission, treatment completion rate, psychological scale, Psychological measures, Brain MRI, Gene expression (at the end of CBT)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients with eating disorders diagnosed by DSM-5
2) 18 years old or older
3) Body mass index (BMI) at screening is greater than 15 kg/m2 (or standard body weight-35%) and less than 40.0 kg / m2 (for outpatient treatment. In case of inpatient, lesser body weight is acceptable)
4) Native Japanese speakers
5) A person who understands the purpose and contents of this research and obtains written consent to participate in the research voluntarily

Key exclusion criteria

1) Those who have severe physical illness and need advanced physical treatments
2) Psychoatric disorders (schizophrenia, bipolar disorder, alcohol abuse / dependency, autism) preceding the history of eating disorders.
3) Persons with intellectual disabilities
4) High risk of suicide
5) MRI examination risk (body metal, possibility of pregnancy, claustrophobia, etc.)
6) Those who are expected to have difficulty visiting and receiving evaluations according to the research schedule
7) Those who are judged to be unsuitable for the research

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Atsushi
Middle name
Last name Sekiguchi

Organization

National institute of mental health, National Center of Neurology and Psychiatry

Division name

Behavioral Medicine

Zip code

187-8553

Address

4-1-1, Ogaewa-higashi, Kodaira, Tokyo

TEL

042-341-2711

Email

asekiguchi@ncnp.go.jp


Public contact

Name of contact person

1st name Atsushi
Middle name
Last name Sekiguchi

Organization

National institute of mental health, National Center of Neurology and Psychiatry

Division name

Behavioral Medicine

Zip code

187-8553

Address

4-1-1, Ogaewa-higashi, Kodaira, Tokyo

TEL

042-341-2711

Homepage URL


Email

asekiguchi@ncnp.go.jp


Sponsor or person

Institute

National Center of Neurology and Psychiatry

Institute

Department

Personal name



Funding Source

Organization

Japanese Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee, National Center of Neurology and Psychiatry

Address

4-1-1, Ogaewa-higashi, Kodaira, Tokyo

Tel

042-341-2711

Email

ml_rinri-jimu@ncnp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 18 Day


Related information

URL releasing protocol

https://bmjopen.bmj.com/content/11/1/e042685.long

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

191

Results

91 patients in the CBT intervention group, 15 in the TAU group, and 85 in the healthy group, of which 39 in the underweight healthy group have been completed for inclusion. Data collection is ongoing.

Results date posted

2023 Year 09 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 10 Month 24 Day

Date of IRB

2019 Year 10 Month 24 Day

Anticipated trial start date

2020 Year 01 Month 06 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

To elucidate the cognitive neuroscience background of the effects of cognitive-behavioral therapy, we conduct brain MRI, blood sampling and psychological evaluation before and after cognitive-behavioral therapy for patients with eating disorders.
As control groups, we evaluate patients with eating disorders before and after treatment other than cognitive behavioral therapy, and evaluate healthy controls, as well.


Management information

Registered date

2020 Year 03 Month 17 Day

Last modified on

2023 Year 09 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045438


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name